<?xml version="1.0" encoding="UTF-8"?>
<document id="27893709">
	<sentence id="s1" text="Here, integrative genomic analysis identified MYST3 as a potential oncogene target that is frequently amplified in breast cancer.">
		<entity id="s1.e1" charOffset="46-51"
			type="GENE" text="MYST3" ontology_id="7994"/>
		<entity id="s1.e2" charOffset="122-128"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="We found that MYST3 was amplified in 11% and/or overexpressed in 15% of breast tumors, and overexpression of MYST3 correlated with worse clinical outcome in estrogen receptor+ (ER+) breast cancers.">
		<entity id="s2.e1" charOffset="14-19"
			type="GENE" text="MYST3" ontology_id="7994"/>
		<entity id="s2.e2" charOffset="79-85"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="189-195"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Interestingly, MYST3 depletion drastically inhibited proliferation in MYST3-high, ER+ breast cancer cells, but not in benign breast epithelial cells or in MYST3-low breast cancer cells.">
		<entity id="s3.e1" charOffset="15-20"
			type="GENE" text="MYST3" ontology_id="7994"/>
		<entity id="s3.e2" charOffset="93-99"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
</document>
